Maryland Health Care Product Development Corporation Invests in Gliknik Inc.
BALTIMORE, June 8 /PRNewswire/ — Biopharmaceuticals company Gliknik Inc. announced today that the Maryland Health Care Product Development Corporation (MHCPDC) has completed an equity investment in the company.
Read more on redOrbit
- New Health & Wellness Center Exclusive To PBSO
- Health Partners America, LLC, Announces Launch of Customizable Private Exchange Technology to Enable Insurance Agents to Participate in Growing Defined Contribution Health Insurance Market
- Health Care?
- Employers’ Health Cost Savings of up to $945 Billion Possible from Risk Reduction and Prevention over Next Decade
- Health Care USA: Understanding Its Organization and Delivery